Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.atherosclerosis.2015.12.032
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for:
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleAtherosclerosis
ISSN00219150
Volume246
IssueMarch
Pages7886; # of pages: 9
Subjectcholesterol; cholesterol/absorption; cholesterol/cell and tissue; drug therapy/hypolipidemic drugs; genetics; proteomics
Abstract
Publication date
LanguageEnglish
Peer reviewedYes
IdentifierS0021915015302616
NPARC number21277181
Export citationExport as RIS
Report a correctionReport a correction
Record identifier23d17299-47db-47c2-8391-f5a1b9ba5426
Record created2016-01-05
Record modified2019-06-20
Date modified: